Refine Search
(14)
(81)
(264)
(361)

Sandhoff Disease (Jatzkewitz-Pilz Syndrome) - Pipeline Review, H2 2017

  • $2,000
  • August 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Sandhoff Disease (Jatzkewitz-Pilz Syndrome) - Pipeline Review, H2 2017’, provides an overview of the Sandhoff Disease (Jatzkewitz-Pilz Syndrome) pipeline landscape.

The report provides comprehensive information ...

Tissue Factor Pathway Inhibitor (Extrinsic Pathway Inhibitor or EPI or Lipoprotein Associated Coagulation Inhibitor or LACI or TFPI) - Pipeline Review, H2 2017

  • $3,500
  • July 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Tissue Factor Pathway Inhibitor (Extrinsic Pathway Inhibitor or EPI or Lipoprotein Associated Coagulation Inhibitor or LACI or TFPI) - Pipeline Review, H2 2017’, provides in depth analysis on Tissue Factor Pathway Inhi...

Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) - Pipeline Review, H2 2017

  • $3,500
  • July 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) - Pipeline Review, H2 2017’, provides in depth analysis on Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU o...

Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) - Pipeline Review, H2 2017

  • $3,500
  • July 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) - Pipeline Review, H2 2017’, provides in depth analysis on Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Rec...

Mitogen Activated Protein Kinase 9 (c Jun N Terminal Kinase 2 or JNK 55 or Stress Activated Protein Kinase JNK2 or Stress Activated Protein Kinase 1a or MAPK9 or EC 2.7.11.24) - Pipeline Review, H1 2017

  • $3,500
  • June 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Mitogen Activated Protein Kinase 9 (c Jun N Terminal Kinase 2 or JNK 55 or Stress Activated Protein Kinase JNK2 or Stress Activated Protein Kinase 1a or MAPK9 or EC 2.7.11.24) - Pipeline Review, H1 2017’, provides in d...

Mitogen Activated Protein Kinase Kinase Kinase 7 (Transforming Growth Factor Beta Activated Kinase 1 or MAP3K7 or EC 2.7.11.25) - Pipeline Review, H1 2017

  • $3,500
  • June 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Mitogen Activated Protein Kinase Kinase Kinase 7 (Transforming Growth Factor Beta Activated Kinase 1 or MAP3K7 or EC 2.7.11.25) - Pipeline Review, H1 2017’, provides in depth analysis on Mitogen Activated Protein Kinas...

Bromodomain Testis Specific Protein (Cancer/Testis Antigen 9 or RING3 Like Protein or BRDT) - Pipeline Review, H1 2017

  • $3,500
  • June 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Bromodomain Testis Specific Protein (Cancer/Testis Antigen 9 or RING3 Like Protein or BRDT) - Pipeline Review, H1 2017’, provides in depth analysis on Bromodomain Testis Specific Protein (Cancer/Testis Antigen 9 or RIN...

Opioid-Induced Bowel Dysfunction (OBD or OIBD) - Pipeline Review, H1 2017

  • $2,000
  • June 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Opioid-Induced Bowel Dysfunction (OBD or OIBD) - Pipeline Review, H1 2017’, provides an overview of the Opioid-Induced Bowel Dysfunction (OBD or OIBD) pipeline landscape.

The report provides comprehensive inform...

Gaucher Disease Type III - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Gaucher Disease Type III - Pipeline Review, H2 2016’, provides an overview of the Gaucher Disease Type III pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...

Charcot-Marie-Tooth Disease Type I A - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Charcot-Marie-Tooth Disease Type I A - Pipeline Review, H2 2016’, provides an overview of the Charcot-Marie-Tooth Disease Type I A pipeline landscape.

The report provides comprehensive information on the therape...

Neurofibromatoses - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Neurofibromatoses - Pipeline Review, H2 2016’, provides an overview of the Neurofibromatoses pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Neurofibro...

Tankyrase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 5 or Poly [ADP Ribose] Polymerase 5A or TRF1 Interacting Ankyrin Related ADP Ribose Polymerase or TNKS or EC 2.4.2.30) - Pipeline Review, H2 2016

  • $3,500
  • August 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Tankyrase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 5 or Poly [ADP Ribose] Polymerase 5A or TRF1 Interacting Ankyrin Related ADP Ribose Polymerase or TNKS or EC 2.4.2.30) - Pipeline Review, H2 2016’, provides in ...

Transient Receptor Potential Cation Channel Subfamily A Member 1 (Ankyrin Like With Transmembrane Domains Protein 1 or Transformation Sensitive Protein p120 or TRPA1) - Pipeline Review, H2 2016

  • $3,500
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Transient Receptor Potential Cation Channel Subfamily A Member 1 (Ankyrin Like With Transmembrane Domains Protein 1 or Transformation Sensitive Protein p120 or TRPA1) - Pipeline Review, H2 2016’, provides in depth anal...

Transient Receptor Potential Cation Channel Subfamily M Member 8 (Long Transient Receptor Potential Channel 6 or Transient Receptor Potential p8 or TRPM8) - Pipeline Review, H2 2016

  • $3,500
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Transient Receptor Potential Cation Channel Subfamily M Member 8 (Long Transient Receptor Potential Channel 6 or Transient Receptor Potential p8 or TRPM8) - Pipeline Review, H2 2016’, provides in depth analysis on Tran...

Charcot-Marie-Tooth Disease - Pipeline Review, H2 2016

  • $2,000
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Charcot-Marie-Tooth Disease - Pipeline Review, H2 2016’, provides an overview of the Charcot-Marie-Tooth Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under develo...